Blueprint Medicines shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Blueprint Medicines
Tip: Access up to 7 years of quarterly data
All positions including Blueprint Medicines held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Blueprint Medicines by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $597k | 6.5k | 92.24 |
| 2023-06-30 | $821k | 13k | 63.20 |
| 2023-03-31 | $1.1M | 24k | 44.99 |
| 2022-12-31 | $633k | 15k | 43.81 |
| 2022-09-30 | $237k | 3.6k | 65.87 |
| 2020-12-31 | $1.1M | 9.5k | 112.13 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management